A plain-language, continually updated guide from Dr. Matt Chalmers’ clinical reference on hormones and peptides.
Selank is a synthetic peptide modeled on tuftsin, a naturally occurring immune-signaling fragment your body produces from antibodies (IgG), modified with an added sequence for stability. It’s a registered pharmaceutical in Russia for anxiety and neurasthenia (a condition involving fatigue and irritability), developed by the same research tradition responsible for Semax.
Selank interacts with the same GABA-A receptor system that benzodiazepines (like Xanax or Valium) target — but at a different binding site, which is why animal and Russian clinical research describes it as reducing anxiety without the sedation, motor impairment, or dependence risk associated with that medication class. It also increases BDNF in brain regions tied to memory and mood, supports neuroplasticity, and appears to prolong the effects of your body’s own natural opioid-like compounds involved in emotional regulation. One practical note: because Selank engages the GABA system directly, it may make benzodiazepines less effective in someone already using it, since that receptor system is already partially engaged.
Neurotrophic signaling pathways (including BDNF) are supported nutritionally by omega-3 fatty acids, B vitamins, magnesium, and zinc in the general neuroscience nutrition literature — the same foundational nutrients relevant to Semax, since both compounds engage overlapping neurological pathways.
Selank is not FDA-approved for any indication in the United States. It is a registered pharmaceutical in Russia for anxiety and neurasthenia. This page describes research findings only — it is not a claim about effects in humans and not an offer to treat any condition.
Selank has some evidence for reducing anxiety, mainly from small Russian clinical trials, but the data are limited and have not been repeated in large Western studies. Clinically, people do report feeling less anxiety and stress with it.
The available evidence does not show Selank to be habit-forming the way benzodiazepines are. That is a big reason some people prefer to try it first. Any time we can lower the risk of dependence, that is a better option. Talk with your provider before changing any current medication.
With nasal use, Selank’s effects are reported to start fairly quickly, usually within about 15 to 60 minutes.
Selank is not a sleep aid and won’t help with sleep in the traditional way. That said, reducing anxiety is often a good way to calm the mind down so you can sleep.
Selank is taken as nasal drops or spray. Common doses are about 0.25 to 0.9 mg (250 to 900 mcg) per dose, 2 to 3 times a day, for a daily total of roughly 0.9 to 2.7 mg. One frequently cited Russian protocol is about 0.3 mg three times a day (0.9 mg a day). A 2008 trial in anxiety used 0.9 mg three times a day (2.7 mg a day) for 14 days.
Selank appears to be generally well tolerated in short-term Russian clinical use, with mild side effects.
This page draws on The Pillars Path: A Root-Cause Guide to Hormones, Peptides, and Metabolic Health by Dr. Matt Chalmers — Pillars of Wellness’ clinical reference on hormone and peptide therapy.
